Home > Back to Publisher > Report Information

Chinese Markets for Prostate Cancer Treatment Drugs

Asia Market Information & Development Company
February 1, 2009
204 Pages - SKU: ASM2090190

Abstract Table of Contents Search inside this report Related Reports

Countries covered: China

China's demand for Prostate Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

I.INTRODUCTION: Report Scope and Methodology; Executive Summary
II.BUSINESS ENVIRONMENT: Economic Outlook; Key Economic Indicators; Industrial Output; Population and Labor; Foreign Investment; Foreign Trade; Financial and Tax Regulations; Banking System and Regulations; Foreign Exchange; Taxes, Tariff and Custom Duties
III.PROSTATE CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS: Prostate Cancer Treatment Drugs Industry Structure; Market Size; Market Growth Drivers; Prostate Cancer Treatment Drugs Sales Volume; Major Producer Facility Locations and Sales Volume; Market Share of Key Producers; Labor Cost; Potential Entrants; Major Distributors; Major Foreign Investments; Technology Development
IV. PROSTATE CANCER TREATMENT DRUGS PRODUCTION AND DEMAND: Overview; Demand of Prostate Cancer Treatment Drugs by Region in 2008; Prostate Cancer Treatment Drugs Sales Volume; Bicalutamide Sales volume and market share; Flutamide Sales volume and market share; Cyproterone Acetate Sales volume and market share; Megestrol Acetate Sales volume and market share; Triptorelin Acetate Sales volume and market share; Goserelin Acetate Sales volume and market share; Leuprorelin Acetate Sales volume and market share; Estramustine disodium phosphate Sales volume and market share; Docetaxel Sales volume and market share; Other Prostate Cancer Treatment Drugs Sales volume and market share; Prostate Cancer Treatment Drugs Imports; Pricing Trends
V. PROSTATE CANCER TREATMENT DRUGS MARKET OUTLOOK: Prostate Cancer Treatment Drugs Markets Outlook Overview; Government Regulations; Health Care Insurance Industry Overview; Health Care Industry Trends; Hospitals and Hospital Beds; Physicians and Physician Visits
VI. MARKETING STRATEGIES: Distribution System in China; China's Distribution System; Prostate Cancer Treatment Drugs Distribution Channels; Transportation and Freight Infrastructure; Communications; Market Entry Channels; Exporting to China; Export Market Overview; Chinese Trading Practice; Chemical Trade Companies; Import Restrictions in China; Technology Licensing; Technology Licensing Overview; Intellectual Property Protection; Joint Venture; Joint Venture Overview; Advantages and Disadvantages; Wholly Owned Enterprises; Foreign Wholly Owned Enterprises Overview; Advantages and Disadvantages; Other Market Entry Channels; Setting up Sales Offices; Selling to China through Attending Trade Fairs; Contacting Chinese Companies; Advertising; Market Entry Strategies; Understanding Differences; Business Practice Differences; Knowledge of Regulations and Restrictions; Dealing with Governments
VII. PROSTATE CANCER TREATMENT DRUGS PRODUCER DIRECTORY: Prostate Cancer Treatment Drugs Producer Profiles; Distributors and Trading Companies; Research Institutions and Associations
LIST OF TABLES
I. INTRODUCTION: Economic Outlook Summary
II. BUSINESS ENVIRONMENT: Key Economic Indicators; Industrial Output; Population and Labor Force Trends; Foreign Investment and Loans; Foreign Trade
III.PROSTATE CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS: Prostate Cancer Treatment Drugs Sales Volume; Major Producer Facility Locations; Major Prostate Cancer Treatment Drugs Producer Sales Volume; Market Share of Key Producers; Major Foreign Investments
IV.PROSTATE CANCER TREATMENT DRUGS PRODUCTION AND DEMAND: Total Prostate Cancer Treatment Drugs Sales Volume; Prostate Cancer Treatment Drug Major Producer and Their Market Share; Chemotherapeutic Drug Major Producer and Their Market Share; Bicalutamide Major Producer and Their Market Share; Flutamide Major Producer and Their Market Share; Cyproterone Acetate Major Producer and Their Market Share; Megestrol Acetate Major Producer and Their Market Share; Luteinizing Hormone Releasing Hormonr Analogue Major Producer and Their Market Share; Triptorelin Major Producer and Their Market Share; Goserelin Acetate Major Producer and Their Market Share; Leuprorelin Acetate Major Producer and Their Market Share; Estramustine phosphate Major Producer and Their Market Share; Docetaxel Major Producer and Their Market Share; Prostate Cancer Treatment Drugs Import
V.PROSTATE CANCER TREATMENT DRUGS MARKET OUTLOOK: Consumer Spending Trend; Demographic Trends; Health Care Industry Trends; Hospitals and Hospital Beds; Physicians and Physician Visits
LIST OF CHARTS
I. NTRODUCTION: Prostate Cancer Treatment Drugs Sales Volume
II. BUSINESS ENVIRONMENT: China's GDP and Industrial Output; Industrial Output by Ownership; China’s Imports and Exports
III.PROSTATE CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS: Prostate Cancer Treatment Drugs Sales Volume; Androgen Receptor Antagonist Sales Volume by Drugs Classification; Luteinizing Hormone Releasing Hormonr Analogue Sales Volume by Drugs Classification; Prostate Cancer Treatment Drugs Sales Volume
IV.PROSTATE CANCER TREATMENT DRUGS PRODUCTION AND DEMAND: Prostate Cancer Treatment Drugs Sales Volume; Worldwide Prostate Cancer Treatment Drugs Demand by region; Androgen Receptor Antagonist Sales Volume and Market Share; Androgen Receptor Antagonist Sales Volume by Drugs Classification; Bicalutamide Sales Volume and Market Share; Flutamide Sales Volume and Market Share; Cyproterone Acetate Sales Volume and Market Share; Megestrol Acetate Sales Volume and Market Share; Luteinizing Hormone Releasing Hormonr Analogue Sales Volume and Market Share; Luteinizing Hormone Releasing Hormonr Analogue Sales Volume by Drugs Classification; Triptorelin Sales Volume and Market Share; Goserelin Acetate Sales Volume and Market Share; Leuprorelin Acetate Sales Volume and Market Share; Estramustine phosphate Sales Volume and Market Share; Docetaxel Sales Volume and Market Share; Other Prostate Cancer Treatment Drugs Sales Volume and Market Share; Prostate Cancer Treatment Drugs Import Volume; Androgen Receptor Antagonist Import and Market Share; Androgen Receptor Antagonist Import by Drugs Classification; Bicalutamide Import Volume and Market Share; Flutamide Import Volume and Market Share; Cyproterone Acetate Import Volume and Market Share; Megestrol Acetate Import Volume and Market Share; Luteinizing Hormone Releasing Hormone Analogue Import Volume and Market Share; Luteinizing Hormone Releasing Hormone Analogue Import by Drugs Classification; Leuprorelin Acetate Import Volume and Market Share; Triptorelin Import Volume and Market Share; Goserelin Acetate Import Volume and Market Share; Estramustine phosphate Import Volume and Market Share; Docetaxel Import Volume and Market Share; Other Import Volume and Market Share
VI. MARKETING STRATEGIES: China’s Distribution Channel

More China Men's Health Reports

Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020 by GlobalData
Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020 Summary GlobalData's pharmaceutical report, “Prostate Cancer - Brazil, Russia, India and China ...

See all reports like this >>

More China Reports

D&B Country RiskLine Report: China by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

Country Report China February 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Country Report China January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

D&B Country Report: China by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Juice – China – a snapshot (2010) by Mintel - Snapshots
Juice in China by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. The report covers packaged ...

See all reports like this >>

Chinese Markets for Prostate Cancer Treatment Drugs

Share this report

Other tasks

Research Assistance

Related Markets

Men's Health Reports

Free Alert Me service